Arena Pharmaceuticals News

Good news for the overweight: Three biotechnology companies say the battle with the bulge is about chemicals in your body, not just a lack of will to exercise and cut calories.

Good news for the overweight: Three San Diego biotechnology companies say the battle with the bulge is about chemicals in your body, not just a lack of will to exercise and cut calories.

Arena Pharmaceuticals Arena Pharmaceuticals, Inc. announced today that the company is scheduled to present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June ...

Arena Pharmaceuticals, Inc. announced today that the company is scheduled to present at Citigroup's Global Healthcare Conference on May 22, 2008 at 8:30 a.m. Eastern Time at the Hilton New York Hotel in New ...

Robert Hoffman - Vice President of Finance and Chief Financial Officer Jack Lief - Chairman, President and Chief Executive Officer William Shanahan - Vice President and Chief Medical Officer Analysts Alan Carr ... via Seeking Alpha

Job Title: Senior Medical Writer FLSA Status: Exempt Job Number: 02500308 Department: Clincal Development Description: The Senior Medical Writer will be responsible for reviewing and preparing ... via BioSpace

Arena Pharmaceuticals, Inc. announced today that the company is scheduled to present at the Bank of America 2008 Healthcare Conference on May 14, 2008 at 5:20 p.m. Pacific Time at the Four Seasons Hotel in Las ... via Freshnews

Arena Pharmaceuticals Inc. said Wednesday its first-quarter loss widened on an increase in research and development costs and general and administrative expenses. via Canadian Business Magazine

Paparazzi and red-carpet interviews, boxing in the Grand Arena, Elvis' Chapel, gambling, dancing in the Heartthrob Lounge and dinner in the Showtime Supper Club were highlights of Sacred Heart School's annual ... via Palo Alto Daily News

“Results from this trial are expected around year end, and we believe they will increase our understanding of APD125 while supporting ongoing partnership efforts.”

Main Category: Sleep / Sleep Disorders / Insomnia Also Included In: Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 09 Apr 2008 - 0:00 PDT newsletters Arena Pharmaceuticals, ... via Medical News Today

When it comes to venue sponsorships, there is no shame as long as a company is willing to ante up the bucks. via About.com

After a 17-year hiatus, George Michael is giving the U.S. touring market one more try. via Billboard.com

On March 17th, Arena Pharmaceuticals reported that they will continue with phase III trials after an independent review of unblinded data showed no cardiac safety concerns for the weight loss drug Lorcaserin. via Seeking Alpha

“In my experience, the use of film cameras in a concert scenario can make the production much more complicated and expensive”

Fujinon HD lenses captured a recent concert by pop star Gwen Stefani in Stockton, California, for a DVD release of the artist's live performances during her "Sweet Escape Tour." Los Angeles-based Oil Factory, ... via Digital Video

Check out Daily Entertainment Photos - "Get all the fashion, glamour and scandal here in pictures!" British pop star George Michael is planning to kick off his first North American concert tour in 17 years this ... via KSNE-FM Las Vegas

“We are committed to continued efforts to develop a robust database for submission to the FDA in our efforts to provide patients a novel, safe and effective obesity treatment.”

Obesity Cause and Help A new diet and obesity drug called Lorcaserin hydrochloride for the treatment of obesity from Arena Pharmaceuticals has passed a major safety board review and shows that this obesity pill ... via EMaxHealth

“No one was interested in finding out why the drug was toxic”

Arena Pharmaceuticals Inc. has bet it can develop a drug from the same family as the notorious diet pill combination fen-phen -- and the gamble may be paying off. via Los Angeles Times

“This critical milestone assessing month-12 echocardiographic data strongly supports lorcaserin's cardiovascular safety profile”

Arena Pharmaceuticals said yesterday an independent safety monitoring board found the company's experimental obesity drug, lorcaserin, was safe and did not cause any heart valve problems after 12 months. via San Diego Union-Tribune

Shares of Arena Pharmaceuticals Inc . rose Monday after the drug developer said a review of its late-stage obesity drug Lorcaserin shows no heart safety issues after one year. via San Diego Source

PLAN A: Beach House, Papercuts, Calico Horse @ The Casbah . The ethereal Baltimore duo behind Beach House built their indie atmospherics on the sands of, like, time beside the tranquil waters of, you know, ... via San Diego CityBEAT